Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
about
Genetic disorders coupled to ROS deficiencyEvolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementBiochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular systemReactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical IndicationsPost-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegenerationAt the interface of antioxidant signalling and cellular function: Key polyphenol effectsNADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in miceStructure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen speciesMyocyte enhancer factor 2B is involved in the inducible expression of NOX1/NADPH oxidase, a vascular superoxide-producing enzymeEnhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidyNADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in miceDecreased blood pressure in NOX1-deficient miceMitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stressAngiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases.Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells.Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection.Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymesNADPH oxidases in vascular pathology.Redox signaling, vascular function, and hypertension.Cardiac Cell Senescence and Redox Signaling.NADPH oxidases: functions and pathologies in the vasculature.Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice.Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice.Tyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension.Tyrosine nitration of PA700 links proteasome activation to endothelial dysfunction in mouse models with cardiovascular risk factors.Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling.Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.Evolution of the ferric reductase domain (FRD) superfamily: modularity, functional diversification, and signature motifsAngiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation.DC isoketal-modified proteins activate T cells and promote hypertension.Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.Obligatory role for GPER in cardiovascular aging and disease.Nox4-mediated cell signaling regulates differentiation and survival of neural crest stem cells.Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1.Molecular cloning and functional characterization of the dual oxidase (BmDuox) gene from the silkworm Bombyx mori.Role for Nox1 NADPH oxidase in atherosclerosisDexamethasone promotes hypertension by allele-specific regulation of the human angiotensinogen gene
P2860
Q26799545-425FB43F-2645-4604-96A7-BD845F144515Q26861119-25F4BA80-D094-45AD-B14B-210DCE5B20F8Q26991619-3EFEF6EE-8923-4FED-85D5-37BD8BE9B4A8Q27024762-E37210B7-0ADA-48C6-AC82-B17D677D3CB9Q27323209-63644B77-FD4B-4814-879F-6A698EECE7EAQ28071627-F2A3BBFD-AD61-4518-A998-35FD13371A6AQ28072348-AA83749B-F526-439E-98BD-CE7DE352126FQ28269693-9A490BDB-7EAE-4BFE-8546-C7AEEA9C5E13Q28282131-46C9C439-77A4-49DE-9D8E-B27B93B81BCAQ28577306-B2E54E31-1332-428B-A2A5-B9D0D54516C4Q28582157-41A3C3D5-1E78-41E5-8DC1-4F998BD2CC3DQ28585549-E7B892F7-9B65-45CA-9229-88390B4F5276Q28588550-B085F6EC-59C9-4191-A6F6-8722D6ACC812Q28588922-02D46774-97C5-4F6A-BC0C-EFB28ECAAD55Q28660732-E51D3359-E007-4D20-A300-FC3A213F165DQ29347157-588F59D4-2A54-4976-8DB8-DF85F0AEBFD5Q30491877-85C565A2-F951-466F-A336-ECCD9B31F8B7Q30786020-D38B460A-4C88-4CA8-8BDF-75D06662445FQ30842247-31C798C0-08E2-4391-8A41-47916E98CE6BQ33290000-C61A16E1-0378-45A8-8DAF-EAC641038837Q33632089-C139BAFB-6864-429F-98DA-9599C1F62753Q33689229-2553FFE2-2AAC-4927-B473-A35686A6E8A8Q33734782-8324201B-77EB-40FC-A11F-5A9852F08145Q33739287-17DC2A08-559F-474A-9E91-3859D49A26F2Q33799794-DE8E6837-FB09-4568-90F9-761763CD15AAQ33922782-A4C54014-89ED-498C-89E3-04FAC6EAF18EQ34022338-06C6BDEB-090D-481E-9132-6025E7DBF7C3Q34137316-1F05AFB6-176B-4DCA-A58E-3E6CA9464CF0Q34150616-826F4D24-5B72-4CEE-9F0C-4293FBC03298Q34269250-5DA2D6CF-C0F8-4954-BC82-918F115E8061Q34333590-3012FDE4-39AD-4461-9457-7028DF603733Q34419313-69F447F9-94A8-47A1-897B-BD8881410729Q34454645-05209059-FD95-40E5-AF42-F603A93DB849Q34479731-767E97FF-A8C7-436C-9785-F8FC8A7A494FQ34543918-3D28D527-9DCC-4331-B638-549D0DC1333DQ34768099-AF6D0F66-B64E-43B1-871E-28A3D2032182Q34829361-81B52DB4-EE4A-471A-AFD0-2736B478C472Q34925074-CFA5499D-87B0-489C-9274-170AD853852FQ35032392-E5819B89-3D99-4BFA-BD79-F64C860D5E7DQ35126691-71941CD4-7B17-4D58-B848-43286494249A
P2860
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@ast
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@en
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@nl
type
label
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@ast
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@en
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@nl
prefLabel
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@ast
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@en
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@nl
P2093
P3181
P1433
P1476
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice
@en
P2093
Chihiro Yabe-Nishimura
Hiroaki Matsubara
Hiroyuki Yamada
Kazumi Iwata
Kuniharu Matsuno
Masato Katsuyama
Masato Matsuki
Mizuo Miyazaki
Shinji Takai
P304
P3181
P356
10.1161/CIRCULATIONAHA.105.573709
P407
P577
2005-10-01T00:00:00Z